Supplement

In the United Kingdom, the process by which an RNS is supplemented into an FCA-approved issuance program, which is distinct from Supplement in the pure US context.

In the context of a US transaction, the term typically is understood to mean either a Pricing Supplement or a Prospectus Supplement.